Different Concentrations of plain bupivacaine via TAP block in post-herniorraphy pain relief.

Comparative Analgesic Effects of Different Concentrations of Bupivacaine Using Transversus Abdominis Plane Block for Post-Herniorrhaphy Pain Relief: A Randomized, Prospective, Double-Blind Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202603797341811

Enrollment

Registered

2026-03-24

Start date

2020-04-16

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Bupivacaine 0.125

Bupivacaine 0.25

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Male patients 18 to 65 years ASA = I-III Scheduled for elective unilateral inguinal herniorrhaphy Informed written consent was obtained

Exclusion criteria

Exclusion criteria: Patient refusal Body mass index (BMI) = 35 kg/m² Bilateral inguinal herniorrhaphy Emergency inguinal herniorrhaphy Hypersensitivity to bupivacaine Requirement for general anaesthesia History of emotional instability or psychiatric illness.

Design outcomes

Primary

Measure	Time frame
Comparing the Duration of Analgesia between the two group	—

Secondary

Measure	Time frame
Comparison of pain scores at specific times between the groups;Comparing the total analgesic consumption between the groups;Comparing the incidence of TAP - related complications like local anaesthetic toxicity, bleeding, intraperitoneal perforation between the groups.;comparing the patients satisfaction among the groups	—

Countries

Nigeria

Contacts

Public ContactRegina Onwudiwe

Consultant Anaesthetist

dronwudiwe3@yahoo.com+2348060108115

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026